Related references
Note: Only part of the references are listed.European Registry on Helicobacter pylori management (Hp--EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients
Olga P. Nyssen et al.
GUT (2021)
Vonoprazan-containingHelicobacter pyloritriple therapies contribution to global antimicrobial resistance
David Y. Graham et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan
Sho Suzuki et al.
GUT (2020)
Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus
Jyh-Ming Liou et al.
GUT (2020)
Transitioning of Helicobacter pylori Therapy from Trial and Error to Antimicrobial Stewardship
David Y. Graham
ANTIBIOTICS-BASEL (2020)
Randomised controlled trial: susceptibility-guided therapy versus empiric bismuth quadruple therapy for first-line Helicobacter pylori treatment
Qi Chen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
A network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent Clostridium difficile infection
Theodore Rokkas et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2019)
Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea
Beom Jin Kim et al.
GUT AND LIVER (2019)
Comparison of concomitant therapy versus standard triple-drug therapy for eradication of Helicobacter pylori infection: A prospective open-label randomized controlled trial
Sanjeev Kumar Jha et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2019)
Vonoprazan- vs proton-pump inhibitor-based first-line 7-day triple therapy for clarithromycin-susceptible Helicobacter pylori: A multicenter, prospective, randomized trial
Soichiro Sue et al.
HELICOBACTER (2018)
Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States
Hashem B. El-Serag et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
Alessia Savoldi et al.
GASTROENTEROLOGY (2018)
Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication
Chonticha Auesomwang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Comparison of 10 and 14 days of triple therapy versus 10 days of sequential therapy for Helicobacter pylori eradication: A prospective randomized study
Abulgasim Ennkaa et al.
TURKISH JOURNAL OF GASTROENTEROLOGY (2018)
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report
P. Malfertheiner et al.
GUT (2017)
Review: A Japanese population-based meta-analysis of vonoprazan versus PPI for Helicobacter pylori eradication therapy: Is superiority an illusion?
Shou Quan Dong et al.
HELICOBACTER (2017)
Helicobacter pylori infection and antibiotic resistance: a WHO high priority?
Bich N. Dang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-Line Helicobacter pylori Eradication: A Randomized Controlled Trial
Masafumi Maruyama et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
Levofloxacin-based sequential therapy versus classic triple therapy in Helicobacter pylori eradication: A randomized clinical trial
Hamidreza Sherkatolabbasieh et al.
BIOMEDICAL RESEARCH AND THERAPY (2017)
What is antimicrobial stewardship?
O. J. Dyar et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Primary Antibiotic Resistance of Helicobacter pylori in China
Yi Hu et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Review article: the global emergence of Helicobacter pylori antibiotic resistance
I. Thung et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial
Ju Yup Lee et al.
BMC GASTROENTEROLOGY (2016)
Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication
Bojan Tepes et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2016)
Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study
Kazunari Murakami et al.
GUT (2016)
Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial
Joon Sung Kim et al.
GUT AND LIVER (2016)
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
Jyh-Ming Liou et al.
LANCET (2016)
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
Brian Hutton et al.
ANNALS OF INTERNAL MEDICINE (2015)
High-dose Dual Therapy Is Superior to Standard First-line or Rescue Therapy for Helicobacter pylori Infection
Jyh-Chin Yang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Kyoto global consensus report on Helicobacter pylori gastritis
Kentaro Sugano et al.
GUT (2015)
Ten-day triple therapy versus sequential therapy versus concomitant therapy as first-line treatment for Helicobacter pylori infection
Tiing Leong Ang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
A Randomized Controlled Study Comparing Reverse Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Infection
Ping-I Hsu et al.
MEDICINE (2015)
Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade A'' Success Rate for First-Line Helicobacter pylori Eradication
Wei-Chen Tai et al.
BIOMED RESEARCH INTERNATIONAL (2015)
The association between Helicobacter pylori infection and inflammatory bowel disease based on meta-analysis
T. Rokkas et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2015)
Randomized Controlled Trial Comparing 7-Day Triple, 10-Day Sequential, and 7-Day Concomitant Therapies for Helicobacter pylori Infection
Ping-I Hsu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
A randomised clinical trial of 10-day concomitant therapy and standard triple therapy for Helicobacter pylori eradication
Jun Heo et al.
DIGESTIVE AND LIVER DISEASE (2014)
A Microsoft-Excel-based tool for running and critically appraising network meta-analyses-an overview and application of NetMetaXL
Stephen Brown et al.
SYSTEMATIC REVIEWS (2014)
Sequential Therapy for 10 Days Versus Triple Therapy for 14 Days in the First-line Treatment of Helicobacter pylori Infection— A Multicenter, Open-label, Randomized Trial
Jyh-Ming Liou et al.
Clinical Gastroenterology and Hepatology (2013)
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study
Hassan Seddik et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption
Francis Megraud et al.
GUT (2013)
Nonbismuth Quadruple Concomitant Therapy Versus Standard Triple Therapy, Both of the Duration of 10 Days, for First-Line H. Pylori Eradication A Randomized Trial
Sotirios Georgopoulos et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Graphical Tools for Network Meta-Analysis in STATA
Anna Chaimani et al.
PLOS ONE (2013)
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: Result of the HPFEZ randomised study
Mounia Lahbabi et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2013)
Penbactam for Helicobacter pylori eradication: A randomised comparison of quadruple and triple treatment schedules in an Iranian population
Seyedali Seyedmajidi et al.
ARAB JOURNAL OF GASTROENTEROLOGY (2013)
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: A randomized study
Mukesh Nasa et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2013)
Efficacy and safety of sequential therapy versus standard triple therapy in Helicobacter pylori eradication in Kashmir India: a randomized comparative trial
Gul Javid et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2013)
Randomised clinical trial: comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naive patients
H. G. Park et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Effectiveness of three times daily lansoprazole/amoxicillin dual therapy for Helicobacter pylori infection in Korea
Seung Young Kim et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Comparison of levofloxacin-containing sequential and standard triple therapies for the eradication of Helicobacter pylori
Zulfikar Polat et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2012)
Levofloxacin-containing Triple and Sequential Therapy or Standard Sequential Therapy as the First Line Treatment for Helicobacter pylori Eradication in China
Juan Qian et al.
HELICOBACTER (2012)
Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: A prospective, randomized study
Hong Sang Oh et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Ten-day sequential versus triple therapy for Helicobacter pylori eradication: A prospective, open-label, randomized trial
Jun-Won Chung et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea
Y. S. Kim et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
Georgia Salanti et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Efficacy of Levofloxacin and Rifaximin based Quadruple Therapy in Helicobacter pylori Associated Gastroduodenal Disease: A Double-Blind, Randomized Controlled Trial
Kang Hyun Choi et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2011)
14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial
E. Robert Greenberg et al.
LANCET (2011)
Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial
Peter Malfertheiner et al.
LANCET (2011)
Characterization of a Novel Potassium-Competitive Acid Blocker of the Gastric H,K-ATPase, 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Monofumarate (TAK-438)
Jai Moo Shin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study
M. Assem et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2010)
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial
Marco Romano et al.
GUT (2010)
Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design
Jyh-Ming Liou et al.
GUT (2010)
Helicobacter pylori treatment in the era of increasing antibiotic resistance
David Y. Graham et al.
GUT (2010)
Comparison of the once-daily levofloxacin-containing triple therapy with the twice-daily standard triple therapy for first-line Helicobacter pylori eradication: a prospective randomised study
L. -W. Chen et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Ten and Eight-day Sequential Therapy in Comparison to Standard Triple Therapy for Eradicating Helicobacter pylori Infection A Randomized Controlled Study on Efficacy and Tolerability
Omero Alessandro Paoluzi et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2010)
Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradication
Xiao-Zhong Gao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Triple or Quadruple Tetracycline-Based Therapies Versus Standard Triple Treatment for Helicobacter pylori Treatment
Yildiran Songuer et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2009)
Clarithromycin-Amoxycillin-Containing Triple Therapy: A Valid Empirical First-Line Treatment for Helicobacter pylori Eradication in Hong Kong?
Ivan F. N. Hung et al.
HELICOBACTER (2009)
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication -: A randomized trial
Dino Vaira et al.
ANNALS OF INTERNAL MEDICINE (2007)
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication
Enrico C. Nista et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Helicobacter pylori eradication with either seven-day or 10-day triple therapies, and with a 10-day sequential regimen
G Scaccianoce et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
One-week once-daily triple therapy with esomeprazole, levofloxacin and azithromycin compared to a standard therapy for Helicobacter pylori eradication
F Iacopini et al.
DIGESTIVE AND LIVER DISEASE (2005)
Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure
V De Francesco et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
High eradication rates of Helicobacter pylori with a new sequential treatment
A Zullo et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication:: The QUADRATE study
PH Katelaris et al.
GASTROENTEROLOGY (2002)
Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection:: a 24-month follow-up study
GJ Mantzaris et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2002)
One-week triple vs. quadruple therapy for Helicobacter pylori infection -: a randomized trial
X Calvet et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Share Paper
